Literature DB >> 29178251

Seizure and cognitive outcomes after resection of glioneuronal tumors in children.

Andrew M Faramand1, Nicola Barnes2, Sue Harrison2, Roxanna Gunny2, Tom Jacques3, M Zubair Tahir2, Sophia M Varadkar2,3, Helen J Cross2,3,4, William Harkness2, Martin M Tisdall2,3.   

Abstract

OBJECTIVE: Glioneuronal tumors (GNTs) are well-recognized causes of chronic drug-resistant focal epilepsy in children. Our practice involves an initial period of radiological surveillance and antiepileptic medications, with surgery being reserved for those with radiological progression or refractory seizures. We planned to analyze the group of patients with low-grade GNTs, aiming to identify factors affecting seizure and cognitive outcomes.
METHODS: We retrospectively reviewed the medical records of 150 children presenting to Great Ormond Street Hospital with seizures secondary to GNTs. Analysis of clinical, neuroimaging, neuropsychological, and surgical factors was performed to determine predictors of outcome. Seizure outcome at final follow-up was classified as either seizure-free (group A) or not seizure-free (group B) for patients with at least 12-months follow-up postsurgery. Full-scale intelligence quotient (FSIQ) was used as a measure of cognitive outcome.
RESULTS: Eighty-six males and 64 females were identified. Median presurgical FSIQ was 81. One hundred twenty-one patients (80.5%) underwent surgery. Median follow-up after surgery was 2 years, with 92 patients (76%) having at least 12 months of follow-up after surgery. Seventy-four patients (80%) were seizure-free, and 18 (20%) continued to have seizures. Radiologically demonstrated complete tumor resection was associated with higher rates of seizure freedom (P = .026). Higher presurgical FSIQ was related to shorter epilepsy duration until surgery (P = .012) and to older age at seizure onset (P = .043). SIGNIFICANCE: A high proportion of children who present with epilepsy and GNTs go on to have surgical tumor resection with excellent postoperative seizure control. Complete resection is associated with a higher chance of seizure freedom. Higher presurgical cognitive functioning is associated with shorter duration of epilepsy prior to surgery and with older age at seizure onset. Given the high rate of eventual surgery, early surgical intervention should be considered in children with continuing seizures associated with GNTs. Wiley Periodicals, Inc.
© 2017 International League Against Epilepsy.

Entities:  

Keywords:  benign tumors; dysembryoplastic neuroepithelial tumors; epilepsy surgery; gangliogliomas; pediatric neurosurgery

Mesh:

Substances:

Year:  2017        PMID: 29178251     DOI: 10.1111/epi.13961

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  9 in total

1.  Lacosamide in monotherapy in BTRE (brain tumor-related epilepsy): results from an Italian multicenter retrospective study.

Authors:  F Mo; S Meletti; V Belcastro; S Quadri; M Napolitano; L Bello; F Dainese; M Scarpelli; I Florindo; A Mascia; G Pauletto; F Bruno; A Pellerino; G Giovannini; M Polosa; M Sessa; M Conti Nibali; G Di Gennaro; G L Gigli; A Pisanello; F Cavallieri; R Rudà
Journal:  J Neurooncol       Date:  2022-04-09       Impact factor: 4.130

2.  The cognitive functions and seizure outcomes of patients with low-grade epilepsy-associated neuroepithelial tumors.

Authors:  Ming-Guo Xie; Jiao Qiao; Xiongfei Wang; Jian Zhou; Yuguang Guan; Changqing Liu; Meng Zhao; Tianfu Li; Guoming Luan
Journal:  J Neurooncol       Date:  2022-09-02       Impact factor: 4.506

3.  Factors associated with seizure and cognitive outcomes after epilepsy surgery for low-grade epilepsy-associated neuroepithelial tumors in children.

Authors:  Ara Ko; Joon Soo Lee
Journal:  Clin Exp Pediatr       Date:  2019-11-13

4.  Epilepsy surgery for low-grade epilepsy-associated neuroepithelial tumor of temporal lobe: a single-institution experience of 61 patients.

Authors:  Zhe Zheng; Hongjie Jiang; Hemmings Wu; Yao Ding; Shuang Wang; Wenjie Ming; Junming Zhu
Journal:  Neurol Sci       Date:  2021-11-24       Impact factor: 3.830

5.  Seizure outcomes and prognostic factors in patients with gangliogliomas associated with epilepsy.

Authors:  Yue Hu; Huawei Zhang; Aihemaitiniyazi Adilijiang; Jian Zhou; Yuguang Guan; Xueling Qi; Mengyang Wang; Jing Wang; Xiongfei Wang; Changqing Liu; Guoming Luan
Journal:  Front Surg       Date:  2022-08-11

6.  The genomic landscape of dysembryoplastic neuroepithelial tumours and a comprehensive analysis of recurrent cases.

Authors:  Mélanie Pagès; Marie-Anne Debily; Frédéric Fina; David T W Jones; Raphael Saffroy; David Castel; Thomas Blauwblomme; Alice Métais; Marie Bourgeois; Emmanuèle Lechapt-Zalcman; Arnault Tauziède-Espariat; Felipe Andreiuolo; Fabrice Chrétien; Jacques Grill; Nathalie Boddaert; Dominique Figarella-Branger; Rameen Beroukhim; Pascale Varlet
Journal:  Neuropathol Appl Neurobiol       Date:  2022-08-09       Impact factor: 6.250

7.  Early Epilepsy Surgery in Benign Cerebral Tumors: Avoid Your 'Low-Grade' Becoming a 'Long-Term' Epilepsy-Associated Tumor.

Authors:  Catrin Mann; Nadine Conradi; Elisabeth Neuhaus; Jürgen Konczalla; Thomas M Freiman; Andrea Spyrantis; Katharina Weber; Patrick Harter; Felix Rosenow; Adam Strzelczyk; Susanne Schubert-Bast
Journal:  J Clin Med       Date:  2022-10-05       Impact factor: 4.964

8.  MicroRNA519d and microRNA4758 can identify gangliogliomas from dysembryoplastic neuroepithelial tumours and astrocytomas.

Authors:  Anika Bongaarts; Avanita S Prabowo; Andrea Arena; Jasper J Anink; Roy J Reinten; Floor E Jansen; Wim G M Spliet; Maria Thom; Roland Coras; Ingmar Blümcke; Katarzyna Kotulska; Sergiusz Jozwiak; Wieslawa Grajkowska; Figen Söylemezoğlu; José Pimentel; Antoinette Y N Schouten-van Meeteren; James D Mills; Anand M Iyer; Erwin A van Vliet; Angelika Mühlebner; Eleonora Aronica
Journal:  Oncotarget       Date:  2018-06-15

9.  Clinical characteristics of low-grade tumor-related epilepsy and its predictors for surgical outcome.

Authors:  Chenmin He; Lingli Hu; Cong Chen; Zhe Zheng; Bo Jin; Yao Ding; Shuang Wang; Mei-Ping Ding; Junming Zhu; Shan Wang
Journal:  Ann Clin Transl Neurol       Date:  2021-05-31       Impact factor: 4.511

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.